BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Diagnosis
9 results:

  • 1. Clinicopathological Features and Prognosis of Gastrointestinal Metastases From breast Carcinoma: A Clinicopathological Study of 22 Patients.
    Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
    Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
    [No Abstract]    [Full Text] [Related]  

  • 2. Immunohistochemistry of mammary Paget's disease. Cytokeratin 7, GATA3, and HER2 are sensitive markers.
    Arain SA; Arafah M; Said Raddaoui EM; Tulba A; Alkhawaja FH; Al Shedoukhy A
    Saudi Med J; 2020 Mar; 41(3):232-237. PubMed ID: 32114594
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Sonographic Appearance of Lesions Diagnosed as Lobular Neoplasia at Sonographically Guided Biopsies.
    Ferré R; Omeroglu A; Mesurolle B
    AJR Am J Roentgenol; 2017 Mar; 208(3):669-675. PubMed ID: 28075608
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone.
    Huttenlocher S; Dziggel L; Hornung D; Blanck O; Schild SE; Rades D
    Radiat Oncol; 2014 Sep; 9():215. PubMed ID: 25240823
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Symptomatic bone marrow involvement in breast cancer--clinical presentation, treatment, and prognosis: a single institution review of 22 cases.
    Kopp HG; Krauss K; Fehm T; Staebler A; Zahm J; Vogel W; Kanz L; Mayer F
    Anticancer Res; 2011 Nov; 31(11):4025-30. PubMed ID: 22110237
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
    Sundram U; Harvell JD; Rouse RV; Natkunam Y
    Mod Pathol; 2003 Aug; 16(8):802-10. PubMed ID: 12920225
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Galactoscopy--is it a new interventional method for breast diagnosis?].
    Schulz-Wendtland R; Aichinger U; Krämer S; Schaaf H; Tartsch M; Bautz W
    Rofo; 2002 Aug; 174(8):1015-7. PubMed ID: 12142980
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International breast cancer Study Group (formerly Ludwig Group).
    Spataro V; Price K; Goldhirsch A; Cavalli F; Simoncini E; Castiglione M; Rudenstam CM; Collins J; Lindtner J; Gelber RD
    Ann Oncol; 1992 Nov; 3(9):733-40. PubMed ID: 1450062
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.